These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 25046649)

  • 41. Design, synthesis, and biological evaluation of novel 2-((2-(4-(substituted)phenylpiperazin-1-yl)ethyl)amino)-5'-N-ethylcarboxamidoadenosines as potent and selective agonists of the A2A adenosine receptor.
    Preti D; Baraldi PG; Saponaro G; Romagnoli R; Aghazadeh Tabrizi M; Baraldi S; Cosconati S; Bruno A; Novellino E; Vincenzi F; Ravani A; Borea PA; Varani K
    J Med Chem; 2015 Apr; 58(7):3253-67. PubMed ID: 25780876
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synthesis and SAR studies of analogues of 4-(3,3-dimethyl-butyrylamino)-3,5-difluoro-N-thiazol-2-yl-benzamide (Lu AA41063) as adenosine A2A receptor ligands with improved aqueous solubility.
    Mikkelsen GK; Langgård M; Schrøder TJ; Kreilgaard M; Jørgensen EB; Brandt G; Griffon Y; Boffey R; Bang-Andersen B
    Bioorg Med Chem Lett; 2015 Mar; 25(6):1212-6. PubMed ID: 25701253
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pyrrolo- and pyrazolo-[3,4-e][1,2,4]triazolo[1,5-c]pyrimidines as adenosine receptor antagonists.
    Baraldi PG; Saponaro G; Aghazadeh Tabrizi M; Baraldi S; Romagnoli R; Moorman AR; Varani K; Borea PA; Preti D
    Bioorg Med Chem; 2012 Jan; 20(2):1046-59. PubMed ID: 22204739
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Synthesis, structure-affinity relationships, and molecular modeling studies of novel pyrazolo[3,4-c]quinoline derivatives as adenosine receptor antagonists.
    Lenzi O; Colotta V; Catarzi D; Varano F; Squarcialupi L; Filacchioni G; Varani K; Vincenzi F; Borea PA; Dal Ben D; Lambertucci C; Cristalli G
    Bioorg Med Chem; 2011 Jun; 19(12):3757-68. PubMed ID: 21616671
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antioxidant-Conjugated 1,2,4-Triazolo[4,3-
    Falsini M; Catarzi D; Varano F; Ceni C; Dal Ben D; Marucci G; Buccioni M; Volpini R; Di Cesare Mannelli L; Lucarini E; Ghelardini C; Bartolucci G; Menicatti M; Colotta V
    J Med Chem; 2019 Sep; 62(18):8511-8531. PubMed ID: 31453698
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Recent Advances of In-Silico Modeling of Potent Antagonists for the Adenosine Receptors.
    Samanta PN; Kar S; Leszczynski J
    Curr Pharm Des; 2019; 25(7):750-773. PubMed ID: 30836910
    [TBL] [Abstract][Full Text] [Related]  

  • 47. SuperBiHelix method for predicting the pleiotropic ensemble of G-protein-coupled receptor conformations.
    Bray JK; Abrol R; Goddard WA; Trzaskowski B; Scott CE
    Proc Natl Acad Sci U S A; 2014 Jan; 111(1):E72-8. PubMed ID: 24344284
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Substructure-based virtual screening for adenosine A2A receptor ligands.
    van der Horst E; van der Pijl R; Mulder-Krieger T; Bender A; Ijzerman AP
    ChemMedChem; 2011 Dec; 6(12):2302-11. PubMed ID: 22021213
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Adenosine receptor modelling. A1/A2a selectivity.
    Tuccinardi T; Ortore G; Manera C; Saccomanni G; Martinelli A
    Eur J Med Chem; 2006 Mar; 41(3):321-9. PubMed ID: 16427161
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Adenosine receptor modeling: what does the A2A crystal structure tell us?
    Dal Ben D; Lambertucci C; Marucci G; Volpini R; Cristalli G
    Curr Top Med Chem; 2010; 10(10):993-1018. PubMed ID: 20370656
    [TBL] [Abstract][Full Text] [Related]  

  • 51. High ligand efficiency quinazoline compounds as novel A
    Bolteau R; Duroux R; Laversin A; Vreulz B; Shiriaeva A; Stauch B; Han GW; Cherezov V; Renault N; Barczyk A; Ravez S; Coevoet M; Melnyk P; Liberelle M; Yous S
    Eur J Med Chem; 2022 Nov; 241():114620. PubMed ID: 35933788
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Structure of an agonist-bound human A2A adenosine receptor.
    Xu F; Wu H; Katritch V; Han GW; Jacobson KA; Gao ZG; Cherezov V; Stevens RC
    Science; 2011 Apr; 332(6027):322-7. PubMed ID: 21393508
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Strategies for improved modeling of GPCR-drug complexes: blind predictions of serotonin receptors bound to ergotamine.
    Rodríguez D; Ranganathan A; Carlsson J
    J Chem Inf Model; 2014 Jul; 54(7):2004-21. PubMed ID: 25030302
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of homology modeling of G-protein-coupled receptors in light of the A(2A) adenosine receptor crystallographic structure.
    Ivanov AA; Barak D; Jacobson KA
    J Med Chem; 2009 May; 52(10):3284-92. PubMed ID: 19402631
    [TBL] [Abstract][Full Text] [Related]  

  • 55. 8-(2-Furyl)adenine derivatives as A₂A adenosine receptor ligands.
    Dal Ben D; Buccioni M; Lambertucci C; Thomas A; Klotz KN; Federico S; Cacciari B; Spalluto G; Volpini R
    Eur J Med Chem; 2013; 70():525-35. PubMed ID: 24189496
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A Taxicab geometry quantification system to evaluate the performance of in silico methods: a case study on adenosine receptors ligands.
    Kuder KJ; Michalik I; Kieć-Kononowicz K; Kolb P
    J Comput Aided Mol Des; 2020 Jun; 34(6):697-707. PubMed ID: 32112287
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The impact of molecular dynamics sampling on the performance of virtual screening against GPCRs.
    Tarcsay A; Paragi G; Vass M; Jójárt B; Bogár F; Keserű GM
    J Chem Inf Model; 2013 Nov; 53(11):2990-9. PubMed ID: 24116387
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Revisiting a receptor-based pharmacophore hypothesis for human A(2A) adenosine receptor antagonists.
    Bacilieri M; Ciancetta A; Paoletta S; Federico S; Cosconati S; Cacciari B; Taliani S; Da Settimo F; Novellino E; Klotz KN; Spalluto G; Moro S
    J Chem Inf Model; 2013 Jul; 53(7):1620-37. PubMed ID: 23705857
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Discovery of aminoquinazoline derivatives as human A(2A) adenosine receptor antagonists.
    Zhou G; Aslanian R; Gallo G; Khan T; Kuang R; Purakkattle B; De Ruiz M; Stamford A; Ting P; Wu H; Wang H; Xiao D; Yu T; Zhang Y; Mullins D; Hodgson R
    Bioorg Med Chem Lett; 2016 Feb; 26(4):1348-54. PubMed ID: 26781932
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Incorporating backbone flexibility in MedusaDock improves ligand-binding pose prediction in the CSAR2011 docking benchmark.
    Ding F; Dokholyan NV
    J Chem Inf Model; 2013 Aug; 53(8):1871-9. PubMed ID: 23237273
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.